Healthcare Pricing and Reimbursement Issues for Generics & Biosimilars Markets in Europe

 

INDUSTRY
Healthcare

RELEASE DATE
28-Dec-2006
REGION
Europe
DELIVERABLE TYPE
Market Research

RESEARCH CODE
B796-01-00-00-00
SKU
HC01173-EU-MR_05270
Yes
SHARE

Pricing and Reimbursement Issues for Generics & Biosimilars Markets in Europe
Published on: 28-Dec-2006 | SKU: HC01173-EU-MR_05270

Need more details?

$4,950.00

$3,712.50 save 25 %

DownloadLink
Need more details?

This research highlights the various issues affecting the pricing and reimbursement environment for generics in Europe. It includes an overview of the generics market, key trends, country-wise market trends, list of market participants, strategic suggestions and decision support databases.

Executive Summary

  • Executive Summary

Important Terms

  • Definitions

Methodology Of Research

  • The "12 Step" Market Engineering Research Methodology and Process

Overview

  • Market Analysis
  • Scope and Objectives
  • Pricing and Reimbursement
  • The Biosimilars Opportunity

Pharmaceutical Cost-containment Measures

  • Reference Pricing
  • Parallel Trade
  • Generic Substitution
  • Patient Co-payments and Reimbursement

Political/Legal/Regulatory Issues

  • Impact of EU Accession
  • The Roche/Bolar Provision
  • Data Exclusivity and Marketing Authorisation Applications

Group I

Group II

  • Denmark
  • Germany
  • The Netherlands
  • The United Kingdom

Group III

  • Austria
  • Belgium
  • France
  • Italy
  • Portugal
  • Spain

Market Players

Recommendations to Market Participants

DSDs


Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Healthcare research

25 Sep 2026   |   Global   |   Technology Research

Innovations and Growth Opportunities in Advanced Medical Devices, Diagnostic Solutions, and Implantables

The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, diagnostic solutions, and implantables.The issue features advanced medical devices such as peritoneal dialysis fluid system, cold sterilization-based au...

23 Sep 2026   |   Global   |   Technology Research

Programmable Epigenome Editing for Disease Reversal

Programmable epigenome editing is developing as a distinct approach to controlling gene activity without changing the underlying DNA sequence. This report examines the landscape from the core editing technologies and delivery systems through the companies, academic programs and therapeutic applicati...

21 Sep 2026   |   Europe   |   Market Research

HLTH Europe 2026: Five Key Takeaways and Growth Opportunities

HLTH Europe 2026, held in Amsterdam, brought together more than 5,000 stakeholders spanning providers, payers, health systems, technology vendors, start-ups, investors, and policymakers, providing a comprehensive view of the evolving European digital health landscape. Across conference sessions and ...

21 Sep 2026   |   Global   |   Frost Radar

Frost Radar: Smart Nutraceuticals for Brain Health, 2026

This Frost Radar evaluates the evolving smart nutraceuticals landscape as consumer awareness of cognitive health, lifestyle-related stress, and healthy aging creates demand for scientifically validated, natural, and multifunctional brain health solutions. The market remains fragmented, with differen...

18 Sep 2026   |   Global   |   Frost Radar

Frost Radar™: Life Sciences Laboratory Information Management Systems, 2026

Laboratory information management systems (LIMS) have been used in life sciences since laboratories began digitizing sample tracking and data management in the 1970s. Modern LIMS solutions enhance efficiency by automating workflows, improving data accuracy, and enabling seamless integration and offe...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

This research highlights the various issues affecting the pricing and reimbursement environment for generics in Europe. It includes an overview of the generics market, key trends, country-wise market trends, list of market participants, strategic suggestions and decision support databases.
More Information
Deliverable Type Market Research
No Index Yes
Podcast No
Industries Healthcare
WIP Number B796-01-00-00-00
Is Prebook No

Pricing and Reimbursement Issues for Generics & Biosimilars Markets in Europe

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC01173-EU-MR_05270